The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, People's Republic of China.
Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
Int J Nanomedicine. 2024 Aug 27;19:8831-8846. doi: 10.2147/IJN.S474888. eCollection 2024.
Cardiovascular disease (CVD) is a major global health issue with high mortality and morbidity rates. With the advances in nanotechnology, nanoparticles are receiving increasing attention in diagnosing and treating CVD. Previous studies have explored the use of nanoparticles in noninvasive diagnostic technologies, such as magnetic resonance imaging and computed tomography. Nanoparticles have been extensively studied as drug carriers and prognostic factors, demonstrating synergistic efficacy. This review summarized the current applications of nanoparticles in CVD and discussed their opportunities and challenges for further exploration.
心血管疾病（CVD）是一个全球性的重大健康问题，具有高死亡率和发病率。随着纳米技术的进步，纳米粒子在 CVD 的诊断和治疗方面受到越来越多的关注。先前的研究已经探讨了纳米粒子在非侵入性诊断技术中的应用，如磁共振成像和计算机断层扫描。纳米粒子作为药物载体和预后因素已经得到了广泛的研究，显示出协同的疗效。本综述总结了纳米粒子在 CVD 中的应用，并讨论了它们进一步探索的机遇和挑战。
